February 23, 2023 11:49 AM EST
Manufacturing

Man­u­fac­tur­ing roundup: Eli Lil­ly’s Moun­jaro is mov­ing past a short­age — re­port; Mer­ck sells New Jer­sey fa­cil­i­ty  

Tyler Patchen

News Reporter

Eli Lil­ly’s di­a­betes drug Moun­jaro now seems to be avail­able once more.

Ac­cord­ing to a re­port from Bloomberg, the phar­ma gi­ant …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

The elec­tion is Tues­day. What’s at stake for the phar­ma in­dus­try?

'We play to win': As­traZeneca de­tails first re­sults for oral GLP-1 and broad­er obe­si­ty am­bi­tions

Is there room for MASH drugs in a GLP-1 world?

Viking's oral weight loss drug ap­pears to have strong ef­fect in Phase 1 tri­al

BioN­Tech says VEGF bis­pe­cif­ic’s PD-L1 tar­get, com­bo plans will be its edge

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times